Beacon Investment Advisory Services’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $428K | Buy |
2,249
+99
| +5% | +$17K | 0.02% | 195 |
|
|
2026
Q1 | $363K | Hold |
2,150
| – | – | 0.01% | 203 |
|
|
2025
Q4 | $363K | Sell |
2,150
-52
| -2% | -$8.45K | 0.01% | 199 |
|
|
2025
Q3 | $318K | Buy |
2,202
+52
| +2% | +$7.1K | 0.01% | 211 |
|
|
2025
Q2 | $272K | Hold |
2,150
| – | – | 0.01% | 216 |
|
|
2025
Q1 | $275K | Hold |
2,150
| – | – | 0.01% | 210 |
|
|
2024
Q4 | $284K | Sell |
2,150
-200
| -9% | -$28.1K | 0.01% | 212 |
|
|
2024
Q3 | $342K | Sell |
2,350
-300
| -11% | -$43.4K | 0.01% | 209 |
|
|
2024
Q2 | $364K | Hold |
2,650
| – | – | 0.02% | 199 |
|
|
2024
Q1 | $364K | Hold |
2,650
| – | – | 0.02% | 208 |
|
|
2023
Q4 | $360K | Hold |
2,650
| – | – | 0.02% | 208 |
|
|
2023
Q3 | $324K | Sell |
2,650
-277
| -9% | -$35.2K | 0.02% | 225 |
|
|
2023
Q2 | $372K | Buy |
2,927
+75
| +3% | +$9.74K | 0.02% | 217 |
|
|
2023
Q1 | $368K | Sell |
2,852
-205
| -7% | -$26.8K | 0.02% | 209 |
|
|
2022
Q4 | $401K | Hold |
3,057
| – | – | 0.02% | 204 |
|
|
2022
Q3 | $358K | Sell |
3,057
-400
| -12% | -$49.7K | 0.02% | 212 |
|
|
2022
Q2 | $407K | Hold |
3,457
| – | – | 0.02% | 209 |
|
|
2022
Q1 | $450K | Hold |
3,457
| – | – | 0.02% | 219 |
|
|
2021
Q4 | $528K | Hold |
3,457
| – | – | 0.02% | 211 |
|
|
2021
Q3 | $559K | Hold |
3,457
| – | – | 0.02% | 201 |
|
|
2021
Q2 | $566K | Buy |
3,457
+201
| +6% | +$31K | 0.02% | 199 |
|
|
2021
Q1 | $490K | Hold |
3,256
| – | – | 0.02% | 205 |
|
|
2020
Q4 | $493K | Buy |
3,256
+400
| +14% | +$57.2K | 0.02% | 190 |
|
|
2020
Q3 | $387K | Hold |
2,856
| – | – | 0.02% | 185 |
|
|
2020
Q2 | $390K | Hold |
2,856
| – | – | 0.02% | 179 |
|
|
2020
Q1 | $308K | Hold |
2,856
| – | – | 0.02% | 193 |
|
|
2019
Q4 | $344K | Sell |
2,856
-100
| -3% | -$11.2K | 0.02% | 208 |
|
|
2019
Q3 | $294K | Hold |
2,956
| – | – | 0.03% | 202 |
|
|
2019
Q2 | $322K | Hold |
2,956
| – | – | 0.03% | 183 |
|
|
2019
Q1 | $330K | Buy |
+2,956
| New | +$324K | 0.04% | 184 |
|
|
2018
Q4 | – | Sell |
-2,050
| Closed | -$250K | – | 256 |
|
|
2018
Q3 | $250K | Sell |
2,050
-50
| -2% | -$5.89K | 0.02% | 233 |
|
|
2018
Q2 | $231K | Buy |
2,100
+135
| +7% | +$14.4K | 0.02% | 235 |
|
|
2018
Q1 | $210K | Sell |
1,965
-60
| -3% | -$6.65K | 0.02% | 246 |
|
|
2017
Q4 | $216K | Sell |
2,025
-42
| -2% | -$4.49K | 0.02% | 230 |
|
|
2017
Q3 | $230K | Buy |
+2,067
| New | +$221K | 0.02% | 246 |
|
Other funds holding IBB
CB
Beacon Investment Advisory Services's IBB Position: Q2 2026 in Review
Beacon Investment Advisory Services increased its iShares Biotechnology ETF (IBB) stake by 4.6% in Q2 2026, buying an estimated $17K and bringing the position to 2,249 shares worth $428K. The position accounts for 0.02% of the portfolio, ranked #195.
Beacon Investment Advisory Services first reported a position in IBB in Q3 2017 and has held it in 35 quarters since. The position peaked at $566K in Q2 2021. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.
- Beacon Investment Advisory Services held 2,249 shares of iShares Biotechnology ETF worth $428K as of Q2 2026.
- Beacon Investment Advisory Services bought 99 iShares Biotechnology ETF shares in Q2 2026, an estimated $17K.
- iShares Biotechnology ETF made up 0.02% of Beacon Investment Advisory Services's portfolio in Q2 2026, its #195 holding.
- Beacon Investment Advisory Services first reported a position in iShares Biotechnology ETF in Q3 2017 and has held it in 35 quarters since.
- Beacon Investment Advisory Services's iShares Biotechnology ETF position peaked at $566K in Q2 2021.
- 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.
Based on Beacon Investment Advisory Services's 13F filing for Q2 2026, filed 8 Jul 2026.